Evaluation of the Effect of Amiodarone on Prevention of Arrhythmias in Patients underwent Coronary Artery Bypass Graft Surgery
Phase 2
- Conditions
- coronary arthery heart disease.Atherosclerotic heart disease
- Registration Number
- IRCT2016053014372N7
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who completed written consent to participate in the study and candidate for CABG; patients older than 18 years.
Exclusion criteria: diabetes; hypothyroidism or hyperthyroidism Cr> 2; liver failure (increased SGOT; SGPT) and patients with chronic obstructive pulmonary diseases (except asthma; bronchitis and emphysema); AF; under 18 years of age; pregnancy and EF more than 30% are the exclusion criteria.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REPERFUSION VENTRICULAR FIBRILATION. Timepoint: 30 min after declamping. Method of measurement: MONITOR OF EKG.;Arrhythmia. Timepoint: during 24 h of ICU stay. Method of measurement: MONITOR OF EKG AND EKG.
- Secondary Outcome Measures
Name Time Method